TrialJournal of neuro-oncology2012

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.

David A Reardon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.